GUIDELINE FOR SUBMITTING DOCUMENTATION FOR THE STABILITY OF HUMAN DRUGS AND BIOLOGICS

被引:0
|
作者
SHULTZ, RC
机构
来源
FOOD AND DRUG LAW JOURNAL | 1988年 / 43卷 / 02期
关键词
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [21] Strategies for stability testing of biologics
    Glaser, V
    GENETIC ENGINEERING NEWS, 2004, 24 (06): : 52 - 52
  • [22] Documentation of off-label use of biologics in Rheumatoid Arthritis
    Furst, Daniel E.
    Fleischman, Roy
    Kalden, Joachim
    Kavanaugh, Arthur
    Sieper, Joachim
    Mease, Philip
    Smolen, Josef
    Breedveld, Ferrie
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 35 - 51
  • [23] The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics
    Coates, Laura C.
    Tillett, William
    Chandler, David
    Helliwell, Philip S.
    Korendowych, Eleanor
    Kyle, Stuart
    McInnes, Iain B.
    Oliver, Susan
    Ormerod, Anthony
    Smith, Catherine
    Symmons, Deborah
    Waldron, Nicola
    McHugh, Neil J.
    RHEUMATOLOGY, 2013, 52 (10) : 1754 - 1757
  • [24] GUIDELINE FOR THE STUDY OF DRUGS IN THE ELDERLY
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (02): : 182 - 182
  • [26] Documentation and derivation of acute exposure guideline levels.
    Young, R
    Bast, C
    Davidson, K
    Forsyth, C
    Milanez, S
    Norris, J
    Ross, R
    Talmage, S
    Troxel, C
    Lu, PY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 7 - CHAS
  • [27] Guideline for collection, treatment and quality documentation of LCA data
    Carlson, R
    Pålsson, AC
    Notten, P
    Cappellaro, F
    Scalbi, S
    Patyk, A
    PROCEEDINGS OF THE INTERNATIONAL WORKSHOP ON QUALITY OF LIFE CYCLE INVENTORY (LCI) DATA, 2004, 6941 : 51 - 54
  • [28] Seeking common ground on safety for drugs, biologics
    不详
    ASM NEWS, 1997, 63 (02): : 70 - 71
  • [29] THE YEAR'S NEW DRUGS & BIOLOGICS, 2010
    Graul, A. I.
    Cruces, E.
    DRUGS OF TODAY, 2011, 47 (01) : 27 - 51
  • [30] FDA Performance Goals for Approving Drugs and Biologics
    Miller, James Dabney
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (02): : 189 - 191